Andrew Artz

11.8k total citations · 1 hit paper
221 papers, 6.2k citations indexed

About

Andrew Artz is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Andrew Artz has authored 221 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Hematology, 58 papers in Genetics and 56 papers in Oncology. Recurrent topics in Andrew Artz's work include Hematopoietic Stem Cell Transplantation (106 papers), Acute Myeloid Leukemia Research (63 papers) and Acute Lymphoblastic Leukemia research (45 papers). Andrew Artz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (106 papers), Acute Myeloid Leukemia Research (63 papers) and Acute Lymphoblastic Leukemia research (45 papers). Andrew Artz collaborates with scholars based in United States, Canada and United Kingdom. Andrew Artz's co-authors include Koen van Besien, Wendy Stock, Richard A. Larson, William B. Ershler, Lucy A. Godley, Martine Extermann, Arti Hurria, Olatoyosi Odenike, Michael J. Thirman and Johan Flamaing and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrew Artz

212 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International Society of Geriatric Oncology Consensus on Geriatric Assessment in Older Patients With Cancer

2014 1.2k citations Andrew Artz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Artz United States	40	2.9k	1.7k	1.2k	1.1k	883	221	6.2k
Vincent Lévy France	42	829 0.3×	1.3k 0.7×	280 0.2×	481 0.4×	486 0.6×	189	5.3k
Mohamed L. Sorror United States	46	8.4k 2.9×	2.8k 1.7×	123 0.1×	2.9k 2.5×	197 0.2×	160	10.9k
Kenneth R. Carson United States	32	724 0.2×	1.9k 1.1×	107 0.1×	363 0.3×	302 0.3×	150	4.2k
Vijaya Raj Bhatt United States	26	941 0.3×	1.4k 0.8×	117 0.1×	434 0.4×	103 0.1×	245	3.2k
Julia Bohlius Switzerland	38	2.0k 0.7×	2.8k 1.7×	36 0.0×	266 0.2×	409 0.5×	122	6.0k
Vikas Gupta Canada	49	6.6k 2.3×	1.9k 1.1×	54 0.0×	2.0k 1.8×	178 0.2×	438	9.7k
Fernando G. Cosio United States	53	595 0.2×	365 0.2×	60 0.1×	1.4k 1.2×	320 0.4×	143	9.4k
Christopher Bredeson Canada	46	4.5k 1.5×	1.9k 1.1×	26 0.0×	1.6k 1.4×	161 0.2×	170	6.7k
Neil Blumberg United States	49	2.7k 0.9×	699 0.4×	30 0.0×	185 0.2×	716 0.8×	193	7.3k
Lesley Anderson United Kingdom	35	553 0.2×	830 0.5×	44 0.0×	263 0.2×	243 0.3×	155	4.6k

Countries citing papers authored by Andrew Artz

Since Specialization

Citations

This map shows the geographic impact of Andrew Artz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Artz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Artz more than expected).

Fields of papers citing papers by Andrew Artz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Artz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Artz. The network helps show where Andrew Artz may publish in the future.

Co-authorship network of co-authors of Andrew Artz

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Artz. A scholar is included among the top collaborators of Andrew Artz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Artz. Andrew Artz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Artz, Andrew, et al.. (2025). SGLT2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series. Advances in Hematology. 2025(1). 7244013–7244013.

Meyers, Gabrielle, Joseph Bubalo, Elizabeth Eckstrom, et al.. (2024). Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines. Transplantation and Cellular Therapy. 30(7). 646–662.

Fei, Fei, Amar Jariwala, Sheeja T. Pullarkat, et al.. (2024). Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. International Journal of Molecular Sciences. 25(18). 10214–10214. 3 indexed citations

Cohen, Harvey Jay, Andrew Artz, Elizabeth Price, et al.. (2023). Biomarkers of erythropoiesis response to intravenous iron in a crossover pilot study in unexplained anemia of the elderly. Hematology. 28(1). 1–8. 1 indexed citations

Rosa, Corinna La, Ibrahim Aldoss, Dongyun Yang, et al.. (2023). CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients after Stem Cell Transplant. Transplantation and Cellular Therapy. 29(2). S68–S69. 1 indexed citations

Wall, Sarah, Rebecca L. Olin, Vijaya Raj Bhatt, et al.. (2023). The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients. Transplantation and Cellular Therapy. 29(10). 632.e1–632.e10. 8 indexed citations

Wall, Sarah, Ying Huang, Edmund Folefac, et al.. (2023). Slow and Steady Wins the Race: Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Candidates. Blood. 142(Supplement 1). 2432–2432.

Muffly, Lori, Catherine J. Lee, Ankur Varma, et al.. (2022). Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilitates Chimerism and Clearance of Minimal Residual Disease in Older Adults with MDS/AML Undergoing Allogeneic HCT. Transplantation and Cellular Therapy. 28(3). S476–S478. 2 indexed citations

Yao, Janny M., Dongyun Yang, Mary C. Clark, et al.. (2021). Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens. Bone Marrow Transplantation. 57(2). 232–242. 3 indexed citations

10.

Aldoss, Ibrahim, Jianying Zhang, Matthew Mei, et al.. (2020). Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia. American Journal of Hematology. 95(10). 1193–1199. 27 indexed citations

11.

Misra, Maneesh Kumar, Nicholas K. Brown, Michael R. Bishop, et al.. (2019). Effective desensitization for a strong donor‐specific HLA antibody in a case of HLA‐mismatched allogeneic hematopoietic cell transplantation. HLA. 94(3). 307–311. 3 indexed citations

12.

Thakar, Monica S., Larisa Broglie, Brent R. Logan, et al.. (2018). The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. Blood. 133(7). 754–762. 35 indexed citations

13.

Strouse, Christopher, Ying Zhang, Mei‐Jie Zhang, et al.. (2018). Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 24(10). 2072–2080. 47 indexed citations

14.

Liu, Hongtao, Andrew Artz, Richard A. Larson, et al.. (2017). Selinexor Maintenance Is Feasible and Tolerable after Allogeneic Stem Cell Transplant (allo-SCT) for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS). Blood. 130. 3312–3312. 3 indexed citations

15.

Hsu, Jingmei, Andrew Artz, Sebastian Mayer, et al.. (2017). Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biology of Blood and Marrow Transplantation. 24(2). 359–365. 15 indexed citations

16.

Godley, Lucy A., Justin Kline, Richard A. Larson, et al.. (2017). Validation of Pre-Transplant Biomarker Measurement and Risk Score for Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant (HCT). Blood. 130. 4558–4558. 1 indexed citations

17.

Neistadt, Barbara, Rafael Márquez, Amittha Wickrema, et al.. (2016). Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy. Biology of Blood and Marrow Transplantation. 22(11). 2100–2103. 32 indexed citations

18.

Petri, Camille R., Peter H. O’Donnell, Hongyuan Cao, et al.. (2014). Clofarabine-associated acute kidney injury in patients undergoing hematopoietic stem cell transplant. Leukemia & lymphoma. 55(12). 2866–2873. 15 indexed citations

19.

Artz, Andrew. (2012). From Biology to Clinical Practice: Aging and Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(1). S40–S45. 17 indexed citations

20.

Ershler, William B., Sheng Shan, Andrew Artz, et al.. (2005). Serum Erythropoietin and Aging: A Longitudinal Analysis. Journal of the American Geriatrics Society. 53(8). 1360–1365. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact